40 related articles for article (PubMed ID: 16857788)
21. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
22. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
[TBL] [Abstract][Full Text] [Related]
23. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
24. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
[TBL] [Abstract][Full Text] [Related]
26. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
Kaneda A; Feinberg AP
Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
[TBL] [Abstract][Full Text] [Related]
27. The altered DNA methylation pattern and its implications in liver cancer.
De Zhu J
Cell Res; 2005 Apr; 15(4):272-80. PubMed ID: 15857582
[TBL] [Abstract][Full Text] [Related]
28. [Relation between insulin-like growth factor II gene and liver cancer].
Qi L; Mao Y
Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):719-20. PubMed ID: 11038800
[No Abstract] [Full Text] [Related]
29. Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review.
Ali Kamkar MM; Ahmad R; Alsmadi O; Behbehani K
J Diabetes Metab Disord; 2014; 13():57. PubMed ID: 24918094
[TBL] [Abstract][Full Text] [Related]
30. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
31. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
32. Specific molecular markers in hepatocellular carcinoma.
Yao DF; Dong ZZ; Yao M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
[TBL] [Abstract][Full Text] [Related]
33. The role of the IGF axis in hepatocarcinogenesis.
Scharf JG; Braulke T
Horm Metab Res; 2003; 35(11-12):685-93. PubMed ID: 14710347
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma.
El Tayebi HM; Abdelaziz AI
World J Gastroenterol; 2016 Mar; 22(9):2668-77. PubMed ID: 26973407
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
